Effects of growth hormone replacement therapy on bone mineral density in growth hormone deficient adults: a meta-analysis (Q34729703)

4 August 2017

Effects of growth hormone replacement therapy on bone mineral density in growth hormone deficient adults: a meta-analysis (English)

1 reference

Hormone Replacement Therapy

4 August 2017

1 reference

1 reference

Peng Xue

1

1 reference

4 August 2017

Yan Wang

series ordinal

2

1 reference

4 August 2017

Jie Yang

series ordinal

3

1 reference

4 August 2017

Yukun Li

series ordinal

4

1 reference

4 August 2017

17 April 2013

1 reference

International journal of endocrinology

4 August 2017

1 reference

4 August 2017

2013

1 reference

4 August 2017

216107

1 reference

Creative Commons Attribution 3.0 Unported

4 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

The role of GHR and IGF1 genes in the genetic determination of African pygmies' short stature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Targeting the insulin growth factor receptor 1

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Endocrine regulation of longitudinal bone growth

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with GH-treated GH deficiency? A systematic literature analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Growth hormone, insulin-like growth factors, and the skeleton

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Aetiology, diagnosis, and management of hypopituitarism in adult life

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Growth hormone replacement for adult growth hormone deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Circulating levels of IGF-1 directly regulate bone growth and density

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

The Utah paradigm of skeletal physiology: an overview of its insights for bone, cartilage and collagenous tissue organs.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

A comparison of longitudinal measurements in the spine and proximal femur using lunar and hologic instruments

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Growth hormone receptor and serum binding protein: purification, cloning and expression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Quality of life in children and adolescents with growth hormone deficiency: association with growth hormone treatment.

7 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Increased fracture frequency in adult patients with hypopituitarism and GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Growth Hormone (GH) Dose-Response in Young Adults with Childhood-Onset GH Deficiency: A Two-Year, Multicenter, Multiple-Dose, Placebo-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

The effect of gender and age on growth hormone replacement in growth hormone-deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Dynamics of bone turnover in children with GH deficiency treated with GH until final height.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Analysis of short stature cases referred for genetic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652209

Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency

26 October 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F216107

Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency

21 January 2018

1 reference

12 December 2020

Expression of Insulin-Like Growth Factor I in Transgenic Mice with Elevated Levels of Growth Hormone Is Correlated with Growth*

1 reference

12 December 2020

Relative influence of physical activity, muscle mass and strength on bone density

1 reference

12 December 2020

Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults

1 reference

12 December 2020

Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study

1 reference

12 December 2020

Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Effects on insulin sensitivity and body composition of combination therapy with GH and IGF1 in GH deficient adults with type 2 diabetes

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/216107

1 reference

4 August 2017

1 reference

4 August 2017

1 reference